Asia-Pacific
Building a Biomedical Value Chain and Accelerating the Development of the Biomedical Industry
2020-07-29Partner
The Rise of Asia as a Destination of Biotech Investment and Opportunity
2020-07-27Partner
Part II Highlights of BIO Asia-Taiwan 2020 (Day 1): Global Trends in Biotech and the Impact of COVID-19
2020-07-23Partner
Part I Highlights of BIO Asia-Taiwan 2020 (Day 1): The Effect of COVID-19 on Global Biotech Industry
2020-07-22Partner
BIO Asia-Taiwan 2020: Nobel Laureate Prof. Tasuku Honjo Reflects on the Future of Cancer Immunotherapy
2020-07-22Partner
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02